Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...
Continuous glucose monitoring enhanced by geriatric care principles reduced the duration of hypoglycemia without worsening ...
Ascensia Diabetes Care, a global diabetes care company, announces that it is launching the Eversense ® 365 continuous glucose monitoring (CGM ... ("Senseonics") is a medical technology company ...
Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the ...
CMA CGM has declared force majeure over a strike that has closed container terminals across a major swathe of the US ...
Opens in a new tab or window The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type 1 or type 2 diabetes, said maker Senseonics.
By providing continuous, accurate data, CGM is especially useful for remote monitoring, enabling timely interventions and leading to better user health. Medical providers and health system leaders ...
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--UpScriptHealth, the leading direct-to-patient telehealth company providing new distribution channels for pharmaceutical and medical device brands, announced ...